Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Methylprednisolone for Dysphagia after ACDF
NCT02539394Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Aug 2015
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of methylprednisolone in dysphagia (2 arms), sponsored by Hospital for Special Surgery. Primary endpoints: Swallowing Quality of Life Burden at 12 months, Swallowing Quality of Life Eating Desire at 12 months and 8 more. Started Aug 2015; status: completed.
02
Drugs
methylprednisolone
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT02539394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02539394.